Chief Technology Officer Michael Tolentino, MD, is with Aviceda Therapeutics. | Mohamed Genead, MD, CHIEF EXECUTIVE OFFICER, AVICEDA THERAPEUTICS INC 00:10:00
Dr. Genead is an ophthalmologist, serial life-sciences entrepreneur and a global executive and senior leader with over 19 years’ experience in Ophthalmology research and development. He is both a retina specialist and clinical investigator with a proven record of success in developing and launching global ophthalmic products in US and Ex-US markets. He is a co-founder of two ophthalmics companies and advisor/consultant to many biotech companies and healthcare venture firms. Dr. Genead was instrumental in raising over $400 million in venture and institutional capital for several early phase biotech companies.